Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-07-05
2005-07-05
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S373000
Reexamination Certificate
active
06914064
ABSTRACT:
The present invention relates to a novel 1,4-disubstituted piperazine derivatives of Formula I,and their pharmaceutically acceptable acid addition salts having excellent uro-selective α1-adrenoceptor antagonistic activity exceeding those of previously described compounds. The compounds of the present invention hold promise for treating the symptoms of benign prostatic hyperplasia (BPH). The invention also relates to methods for making the novel compounds, pharmaceutical compositions containing the compounds, and method of treating the symptoms of benign prostatic hyperplasia using the compounds.
REFERENCES:
patent: 4479954 (1984-10-01), Hirose et al.
patent: 4524206 (1985-06-01), New et al.
patent: 4598078 (1986-07-01), Ishizumi et al.
patent: 6083950 (2000-07-01), Anand et al.
patent: 6090809 (2000-07-01), Anand et al.
patent: 387 773 (1989-03-01), None
patent: 0 109 562 (1984-05-01), None
patent: 0 111 226 (1984-06-01), None
patent: 0 711 757 (1996-05-01), None
patent: 0748800 (1996-12-01), None
patent: 59036661 (1984-02-01), None
patent: 60-204784 (1985-10-01), None
patent: 02-235865 (1990-09-01), None
patent: WO 98/37893 (1998-09-01), None
patent: WO 98/51298 (1998-11-01), None
Hieble et al., “Recent advances in the identification of alpha1- and alpha2-adrenoceptor subtypes: therapeutic implications”,Expert Opinion on Investigational Drugs 6, pp. 367-387 (1997).
Kenny et al., “Pharmacological Options in the Treatment of Benign Prostatic Hyperplasia”,J. Med. Chem. 40, pp. 1293-1315 (1997).
Cross, et al., “Substituted trifiuoromethyl phenyl piperazines as anoretic-agents”,Eur. J. Med. Chem.—Chimica Therapeutica 12, pp 173-176 (1977).
Van Steen, et al., “A Series of N4-Imidoethyl Derivatives of 1-(2,3-Dihydro-1,4-benzodioxin-5-yl)piperazine as 5-HT1AReceptor Ligands: Synthesis and Structure-Affinity Relationships”,J. Med. Chem. 38, pp. 4303-4308 (1995).
Ishizumi, et al., “Synthesis and Anxiolytic Activity of N-Substituted Cyclic Imides (1R*,2S*, 3R*, 4S*)-N-[4-[4-(2-Pyrimidinyl)-1-piperazinyl]buty]-2,3-bicyclo[2.2.1]heptanedicarboximide (Tandospirone) and Related Compounds1.2)”,Chem. Pharm. Bull. 39(9), pp. 2288-2300 (1991).
New, et al., “Buspirone Analogues. 2. Structure-Activity Relationships of Aromatic Imide Derivatives”,J. Med. Chem, 29, pp. 1476-1482 (1986).
Korgaonkar, et al., “Synthesis of N-[3-(4-Aryl-1-piperazinyl)propyl]-4, 4-bis(4-methoxyphenyl)piperidine,-2,6-diones/Tetrahydrophthalimides/Camphorimides as Sedatives”,J. Indian Chem. Soc. vol. LX, pp. 874-876 (1983).
Khadilkar & Samant, “Synthesis and Pharmacology of Some 2-[3-(4-Aryl-1-piperazinyl)propyl]-1H-benz[de]isoquinolin-1,3(2H)-diones/2,5-pyrrolinediones”,J. Indian Chem. Soc.: vol. LXIII, pp. 529-530 (1986).
Samant & Kulkarni, “N-(N4-Aryl-N1piperazinylmethyl)-4-(4-methoxyphenyl)-piperdine-2,6-diones: CNS Depressants”,J. Indian Chem. Soc. vol. LV, pp. 819-821 (1978).
Samant & Kulkarni, “Synthesis and Pharmacology of N-(N4-Aryl-N1-Piperazinylalkyl) Phthalimides: CNS Depressants”,J. Indian Chem. Soc. vol. LVI, pp. 1002-1005 (1979).
Michel, et al., “Identification of a single α1-adrenoceptor corresponding to the α1A-subtype in rat submaxillary gland”,Br. J. Pharmacol. 98, pp 883-889 (1989).
U'Prichard, et al., “Prazosin: Differential Affinities for Two Populations of α-Noradrenergic Receptor Binding Sites”,Eur. J. of Pharm. 50, pp. 87-89 (1978).
Brune, et al., “Effects of Selective and Nonselective Alpha-1-Adrenoceptor Antagonists on Intraurethral and Arterial Pressures in Intact Conscious Dogs”,Pharmacology 53, pp. 356-368 (1996).
Zagidullin, “N-(.beta.-Aminoethyl)piperazine and its derivatives in aminomethylation reactions”,Zh. Obshch. Khim.,vol. 16, No. 1, pp. 247-253 (1991).
Anand Nitya
Chugh Anita
Gupta Jang Bahadur
Hegde Laxminarayan G.
Jain Sanjay
Bernhardt Emily
Deshmukh Esq. Jayadeep R.
Heibel Esq. George E.
Ranbaxy Laboratories Limited
LandOfFree
1,4-Disubstituted piperazine derivatives useful as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,4-Disubstituted piperazine derivatives useful as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,4-Disubstituted piperazine derivatives useful as... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3398845